Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in IVVD — Invivyd, Inc.

CIK 1214717 BOSTON, MA
Back to IVVD Full portfolio

Position in IVVD

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$4,725,170
+$1,515,566 QoQ
Shares Held
5,418,774
+119.5% QoQ
Ownership
1.84%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 124 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IVVD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. IVVD ranks #249 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in IVVD

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,725,170 5,418,774
2026-03-31 $3,209,604 2,468,927
2025-12-31 $5,079,485 2,056,472
2025-09-30 $805,578 732,344
2025-06-30 $455,424 636,958
2025-03-31 $983,520 1,625,654
2024-12-31 $707,769 1,597,674
2024-09-30 $1,654,664 1,622,221
2024-06-30 $1,799,490 1,635,901
2024-03-31 $2,714,877 611,459
2023-12-31 $2,289,494 581,090
2023-09-30 $924,222 543,660
2023-06-30 $543,473 517,594
2023-03-31 $1,244,636 1,037,197
2022-12-31 $1,532,782 1,021,855
2022-09-30 $3,071,303 981,247
2022-06-30 $2,357,306 718,691
2022-03-31 $2,917,000 639,693
2021-12-31 $2,742,719 377,785
2021-09-30 $15,714,589 372,031